Breadcrumb

[A16-30] Emtricitabine/tenofovir alafenamide - Benefit assessment according to §35a Social Code Book V

Overview

Overview

Commission: Commission awarded on 2016-05-13 by the Federal Joint Committee (G-BA)
Status:Commission completed
Department/Division:Drug Assessment
Current document:PDF Extract of dossier assessment  [PDF, 435 kB]Further documents
Note:

The current version 1.1 of the dossier assessment replaces version 1.0 published on 15 August 2016.


After completion of the assessment by IQWiG the Federal Joint Committee (G-BA) conducts a commenting procedure. This may provide supplementary information and as a result lead to a modified benefit assessment. Further information and the decision on the early benefit assessment can be found on the relevant page of the G-BA website.

Contact address:to the contact form
Linked projects: [A16-58] Emtricitabine/tenofovir alafenamide (HIV) - Addendum to Commission A16-30
Status: Commission completed


Report documents

Report documents

PublishedDocumentSizeType 
2016-09-30 Extract of dossier assessment 435 kBPDFdownload file
2016-09-30 Dossier assessment (German version) 844 kBPDFdownload file

The current version 1.1 of the dossier assessment replaces version 1.0 published on 15 August 2016.

After completion of the assessment by IQWiG the Federal Joint Committee (G-BA) conducts a commenting procedure. This may provide supplementary information and as a result lead to a modified benefit assessment. Further information and the decision on the early benefit assessment can be found on the relevant page of the G-BA website.


At a glance

Accompanying information

Extract of dossier assessment

  File-Icon  Emtricitabine/tenofovir alafenamide - Benefit assessment according to §35a Social Code Book V [PDF, 435 kB]

Federal Joint Committee (G-BA)

2016-11-03 A G-BA decision was published.

G-BA documents on this decision

Press releases

2016-08-15 Emtricitabine/tenofovir alafenamide in HIV infection: added benefit not proven



Save result list

To save your search result, please copy the link below and paste it into a new tab/window.

close